Max Healthcare Institute: Prabhudas Lilladher Recommends BUY with Rs 1,400 Target Amid Strong Growth Forecast

Overview

Prabhudas Lilladher has issued a 'BUY' recommendation for Max Healthcare Institute, setting a price target of Rs 1,400 per share. The report highlights strong EBITDA growth of 23% year-on-year to Rs 6.94 billion and an expected EBITDA CAGR of approximately 19% from FY22 to FY25. Key growth drivers include significant expansion plans adding 3,700 beds by FY28, a better payor mix, and strategic acquisitions. Operational efficiency, particularly in competitive markets like NCR, is also noted.